ROBO Global^®

Healthcare Technology and Innovation ETF

Schedule of Investments

July 31, 2021 (Unaudited) 

Description	Shares		Fair Value
COMMON STOCK — 99.8%
Australia — 1.0%
Health Care — 1.0%
CSL		10,907	$	2,316,249
Total Australia				2,316,249
Belgium — 0.6%
Information Technology — 0.6%
Materialise ADR *		66,865		1,455,651
Total Belgium				1,455,651
China — 1.1%
Health Care — 1.1%
Ping An Healthcare and Technology * (A)		278,900		2,601,947
Total China				2,601,947
Denmark — 0.8%
Health Care — 0.8%
GN Store Nord		22,978		2,013,217
Total Denmark				2,013,217
France — 2.5%
Health Care — 2.5%
Cellectis ADR *		225,462		2,919,733
Eurofins Scientific		24,778		2,962,865
Total Health Care				5,882,598
Total France				5,882,598
Germany — 1.5%
Health Care — 1.5%
Siemens Healthineers (A)		55,203		3,644,808
Total Germany				3,644,808
Hong Kong — 1.5%
Health Care — 1.5%
Alibaba Health Information Technology *		1,022,000		1,588,656
JD Health International * (A)		187,100		2,009,149
Total Health Care				3,597,805
Total Hong Kong				3,597,805
Italy — 1.6%
Health Care — 1.6%
DiaSorin		18,295		3,712,975
Total Italy				3,712,975
Japan — 0.7%
Health Care — 0.7%
Terumo		43,600		1,683,218
Total Japan				1,683,218
Netherlands — 0.9%
Health Care — 0.9%
Koninklijke Philips		49,602		2,287,441
Total Netherlands				2,287,441
Switzerland — 4.1%
Health Care — 4.1%
Lonza Group		4,391		3,416,676
Roche Holding		7,324		2,831,252
Tecan Group		5,942		3,425,681
Total Health Care				9,673,609
Total Switzerland				9,673,609
United Kingdom — 1.7%
Health Care — 1.7%
EMIS Group		99,272		1,780,503
Smith & Nephew PLC		107,103		2,177,084
Total Health Care				3,957,587
Total United Kingdom				3,957,587
United States — 81.8%
Health Care — 79.3%
1Life Healthcare *		82,898		2,241,562
Abbott Laboratories		19,494		2,358,384
ABIOMED *		11,320		3,703,225
Agilent Technologies		19,018		2,914,128
Align Technology *		4,555		3,169,369
Alnylam Pharmaceuticals *		11,256		2,014,149
Arrowhead Pharmaceuticals *		21,524		1,491,398
Avanos Medical *		50,671		1,922,458
Axogen *		172,718		3,518,266
Baxter International		25,306		1,957,419
Becton Dickinson		7,489		1,915,312
BioMarin Pharmaceutical *		28,619		2,195,936
Bio-Rad Laboratories, Cl A *		4,849		3,585,884
Boston Scientific *		77,992		3,556,435
Bristol-Myers Squibb		31,045		2,107,024
Cardiovascular Systems *		81,695		3,291,492
CareDx *		38,070		3,199,403
Catalent *		28,188		3,377,204
Cerus *		358,461		1,806,643
Charles River Laboratories International *		9,728		3,958,518
Codexis *		122,852		2,599,548
CONMED		15,071		2,078,894
CryoLife *		95,314		2,573,478
Danaher		13,187		3,923,000
DexCom *		8,557		4,411,218
Editas Medicine, Cl A *		97,359		4,075,448
Edwards Lifesciences *		25,129		2,821,233
Exact Sciences *		28,231		3,044,431

ROBO Global^®

Healthcare Technology and Innovation ETF

Schedule of Investments

July 31, 2021 (Unaudited) 

Description	Shares		Fair Value
Fulgent Genetics *		40,892	$	3,772,287
Glaukos *		44,508		2,269,908
Globus Medical, Cl A *		24,001		1,996,163
Health Catalyst *		57,952		3,364,693
Hologic *		41,031		3,078,966
Illumina *		7,839		3,886,184
Incyte *		36,188		2,799,142
Insulet *		12,058		3,372,502
Integra LifeSciences Holdings *		48,520		3,512,363
Intuitive Surgical *		3,938		3,904,369
Invitae *		90,990		2,546,810
IQVIA Holdings *		12,753		3,158,918
iRhythm Technologies *		50,684		2,590,966
Masimo *		11,407		3,107,153
Medpace Holdings *		15,497		2,726,542
Moderna *		7,950		2,811,120
NanoString Technologies *		46,706		2,892,970
Natera *		33,619		3,850,048
NeoGenomics *		73,736		3,399,230
Nevro *		18,507		2,868,585
Novocure *		7,963		1,226,382
Omnicell *		21,137		3,096,571
Penumbra *		11,669		3,106,638
PerkinElmer		19,461		3,546,378
Quidel *		26,300		3,720,661
Regeneron Pharmaceuticals *		5,889		3,383,878
STAAR Surgical *		11,929		1,525,958
Stryker		9,828		2,662,798
Tabula Rasa HealthCare *		73,941		3,176,505
Tactile Systems Technology *		49,819		2,440,135
Teladoc Health *		11,178		1,659,374
Thermo Fisher Scientific		7,302		3,943,153
Veeva Systems, Cl A *		5,683		1,890,791
Veracyte *		99,518		4,434,522
Vertex Pharmaceuticals *		11,709		2,360,300
Vocera Communications *		94,180		3,951,792
				187,846,214
Information Technology — 2.5%
3D Systems *		67,204		1,850,798
Brooks Automation		23,644		2,104,552
Novanta *		13,533		1,900,169
				5,855,519
Total United States				193,701,733
Total Common Stock
(Cost $222,727,369)				236,528,838
SHORT-TERM INVESTMENT — 0.2%
Invesco Government & Agency, Cl Institutional, 0.03%(B)		475,887		475,887
Total Short-Term Investment
(Cost $475,887)				475,887
Total Investments - 100.0%
(Cost $223,203,256)			$	237,004,725

Percentages based on Net Assets of $236,945,109. 

*	Non-income producing security.
(A)	Securities sold within terms of a private placement memorandum, exempt from registration under Section 144A of the Securities Act of 1933, as amended, and may be sold only to dealers in that program or other “accredited investors.” These securities have been determined to be liquid under guidelines established by the board of Trustees. As of July 31, 2021, the value of these securities amounted to $8,255,904, representing 3.5% of the Net Assets of the Fund.
(B)	Rate shown is the 7-day effective yield as of July 31, 2021.

ADR – American Depository Receipt

Cl – Class

PLC - Public Limited Company

As of July 31, 2021, all of the Fund's investments were considered Level 1 of the fair value hierarchy, in accordance with the authoritative guidance under U.S. GAAP.

For the period ended July 31, 2021, there were no transfers in or out of Level 3.

For information regarding the Trust's policy regarding valuation of investments and other significant accounting policies, please refer to the Trust's most recent semi-annual and annual financial statements.

ROB-QH-001-1600